DZ Bank AG Deutsche Zentral Genossenschafts Bank Frankfurt Am Main 13F Portfolio

The biggest buys table reads like a bet that AI’s hardware cycle is broadening beyond the usual suspects and that defensive growth can still be bought at a reasonable price.

On the AI plumbing side, Dz Bank AG is massively increasing exposure where expectations are lower than for the marquee leaders:

• Intel (INTC) is the standout, with shares up 274.2% and the stake lifted by about $733.4M to 0.79% of the book. That’s a clear statement that the market is underestimating Intel’s role in data center and foundry redistribution.
• Advanced Micro Devices (AMD) is another big swing, with shares up 175.4% and roughly $695.7M added. They’re leaning into the challenger GPU/CPU narrative rather than just riding Nvidia.
• Taiwan Semiconductor (TSM) and Lam Research (LRCX) are also quietly increased, suggesting a full-stack view of the AI build-out rather than a single-name bet.

Outside chips, they are scaling durable cash-flow franchises that benefit from secular trends:

• Mastercard (MA) saw a 107.9% jump in shares, adding about $730.6M and taking it to 1.11% of the portfolio. This is a vote for global transaction growth even if consumer sentiment wobbles.
• In healthcare, AbbVie (ABBV) is boosted 164.4% (+$451.5M) and McKesson (MCK) 47% (+$371.6M). That’s a clear skew toward scale drug and distribution platforms rather than speculative biotech.
• Welltower (WELL) is up 21.2% in shares (+$421.1M), pushing healthcare real estate to the fore as they lean into aging demographics and need-driven demand.
• Amazon (AMZN) gets a 13% share increase (+$529.7M), a measured bet that e-commerce and cloud volumes compound even if AI excitement cools.
• Spotify (SPOT), up 57.4% in shares and about $412.6M in value, signals a willingness to pay for operating leverage in digital subscription models despite some near-term mark-to-market pain.

The sell-side of the ledger is not a repudiation of AI or growth; it’s a harvest of the most extended winners and a rebalance away from crowded trades.

In technology, they’re methodically taking the top off high-multiple names where they already sit on large gains:

• Seagate (STX) is the biggest trim by dollars, with shares cut 41.8% and about $1.46B freed up, despite a gain_vs_avg_buy_pct over 300%. That looks like pure profit-taking in a cyclical storage name that has rerated hard on AI-driven demand hopes.
• ARM Holdings (ARM) is reduced 30.6%, releasing roughly $1.02B, and Nvidia (NVDA) is trimmed 6.1% (-$604.1M) from a still-dominant 7.28% position. Broadcom (AVGO) and Micron (MU) are also dialed back after big runs.
• Meta Platforms (META) gets a 41.9% cut (about -$891.8M), a clear signal that they prefer Alphabet’s risk/reward in the AI+advertising stack given concurrent increases in GOOGL and GOOG.

In cyclicals and industrials, they’re removing some heat where valuations have run ahead of fundamentals:

• Quanta Services (PWR) is slashed 39.5%, freeing about $627.1M after a strong infrastructure build-out rally.
• Aon (AON) is down 23.5% (-$229.7M), a rotation away from fee-rich insurance consulting toward traditional banks where they’ve been adding JPMorgan, Bank of America, and Citigroup.
• Trims in Union Rentals (URI), Tesla (TSLA), and Prologis (PLD) look like incremental risk control in more cyclical or rate-sensitive names rather than thesis breaks.

On the surface, the sector chart suggests stasis: technology barely moves, from 55.2% to 52.67%. Underneath, the risk profile shifts from shiny front-end AI stories toward diversified hardware, foundry, and infrastructure software.

Within tech, they are rotating from mega-cap beneficiaries and high-momentum edge plays into broader, somewhat cheaper enablers:

• Position sizes fall in Nvidia, ARM, Broadcom, Micron, Meta, and Cloudflare (NET), while rising in Intel, AMD, Oracle (ORCL), MongoDB (MDB), and the Alphabet share classes. This is a trade from pure hype-beta to earnings durability and platform leverage.

The rest of the book shows a gradual move toward real assets and healthcare:

• Consumer Discretionary climbs from 10.73% to 12.12%, driven by adds in Amazon, Spotify, TJX, Baker Hughes (BKR), and Casey’s (CASY). That’s a mix of digital growth and old-economy exposure.
• Health Care rises from 8.51% to 9.08% as they build AbbVie, Eli Lilly (LLY), McKesson, and Edwards Lifesciences (EW) while trimming a lagging AstraZeneca (AZN) and Johnson & Johnson (JNJ).
• Real estate jumps from 4.21% to 5.38%, largely via Welltower and a bigger Mastercard stake (classified here in the dataset but functionally a payments name). This underscores a demographic and payments-infrastructure theme.
• Industrials and Energy edge down modestly, reflecting trims in Quanta, FTAI Aviation (FTAI), and TotalEnergies (TTE) after strong performance.

Taken together, these moves say Dz Bank AG is not backing away from AI or growth; it’s maturing the trade. The portfolio leans into the idea that the next leg of returns comes from semis, foundries, and software platforms that monetize AI more quietly, not just the poster children.

The build-out in healthcare majors, distribution, and senior-focused real estate suggests they want ballast that still grows — beneficiaries of aging populations, complex drug pipelines, and chronic-disease management. AbbVie, McKesson, Eli Lilly, and Welltower sit right at that intersection.

Meanwhile, modest but broad-based adds to money-center banks indicate confidence that higher rates and capital-markets activity will support earnings, even if credit normalizes. Keeping top-10 concentration at 33.1% while rotating within sectors fits a playbook of managing factor risk rather than slashing exposure outright.

If the current regime of elevated rates, AI capex, and demographic pressure persists, this book is now more exposed to the infrastructure and distribution layers of that world than to its most speculative frontiers. If those narratives crack, the trims to the most extended winners will look less like leaving money on the table and more like disciplined risk transfer into franchises that can compound through a wider range of outcomes.